What a New Geriatric Trial Found, and What It Didn't
Credit: Daily Vitality
If you or someone you love is managing depression later in life, a new piece of research offers a small, hopeful signal. On June 17, 2026, scientists reported that adding a daily probiotic to standard antidepressant care produced modest but meaningful improvements in depression and anxiety symptoms among adults aged 60 and older. The findings come from a pilot clinical trial known as PRODG, published in the Journal of the American Geriatrics Society.
It's an early result, not a headline cure, and the researchers are careful to say so. But it lands in a corner of science that many people find intuitive: the idea that the trillions of microbes living in your gut might have something to say about how you feel. Here's what the trial actually tested, what it found, and the context that keeps those findings in proportion.
Stay on top of health & wellness news
The trial was small and tightly defined. Researchers enrolled 58 adults in India, all aged 60 or older and all living with moderate depression, then randomly assigned them one-to-one to receive either a daily probiotic or a matching placebo for 12 weeks. Everyone kept taking their standard antidepressant medication throughout, which is the detail that matters most: the probiotic was tested as an adjunct — an add-on — rather than a stand-in for treatment. After those 12 weeks of supplements, participants were followed for another 12 weeks, 24 weeks in total. The work was published in the Journal of the American Geriatrics Society as a randomized, double-blind, placebo-controlled pilot run at two medical centers.
The probiotic itself paired two well-studied strains, Lactobacillus helveticus and Bifidobacterium longum. If the label lingo is unfamiliar, our guide to postbiotics, probiotics, and prebiotics sorts out what each one actually is. To gauge whether the supplement made a difference, the team leaned on more than a single mood questionnaire. Their main yardstick was a depression "response," defined as a reduction of at least 50% on the Montgomery-Åsberg Depression Rating Scale (MADRS). They also tracked anxiety with the GAD-7 scale, along with cognition, quality of life, a blood marker called BDNF, and the makeup of each participant's gut bacteria.
Across the trial, depression and anxiety symptoms eased significantly over time in both groups — a reminder that standard antidepressant care was doing meaningful work on its own. When the two groups were compared, overall symptom scores came out lower, meaning better, in the probiotic group than the placebo group for both depression and anxiety. The researchers describe that edge as "modest but meaningful," and a summary from the study's publisher frames it the same measured way.
There's an important nuance worth sitting with. The improvement curves of the two groups ran largely parallel over the 24 weeks, and the statistical test for a difference in those trajectories did not reach significance. Quality of life improved markedly for everyone, but probiotics added no clear benefit there. Where the probiotic group did stand apart was biological: participants showed higher blood levels of BDNF and a greater abundance of the supplemented strains in their stool samples — signs that the supplement was doing something measurable in the body, even if the symptom edge stayed modest.
"The results of our study are novel, and we are now planning a follow-up, larger-scale clinical trial due to the encouraging findings," said Dr. Saibal Das, a co-corresponding author from the Indian Council of Medical Research – National Institute for Research in Bacterial Infections in Kolkata.
The reason scientists even think to study gut bacteria for depression comes down to a two-way street between your digestive system and your brain. Researchers describe this microbiota-gut-brain axis as a network of signals carried by the vagus nerve, the immune system, and the chemical byproducts that gut microbes make — while stressing that the mechanism is still an active research area, not settled fact.
Probiotics are simply live "good bacteria" that help support a healthy balance in the gut, and the question researchers keep circling is whether nudging that balance can ripple upward to mood. If the idea is new to you, our explainer on psychobiotics walks through how gut bacteria and mental health may be connected.
BDNF is a big part of that story. It's a protein that helps nerve cells grow, function, and survive, and low levels have long been linked with depression — so a rise is seen as a biologically plausible hint that a treatment may be supporting brain health. Even so, the broader evidence is genuinely mixed. A systematic review and meta-analysis of 11 trials involving 648 participants found that probiotics did not significantly change BDNF across the board, even as subgroups of people with depression or neurological conditions did see increases. The same analysis suggested that combined Lactobacillus and Bifidobacterium formulas — the very pairing used in PRODG — looked more promising than single-strain products, while cautioning that the overall quality of evidence remains low.
Depression in later life deserves its own attention, and it doesn't always look the way people expect. The National Institute of Mental Health notes that mental health stays important at every stage of life, that older adults may show sadness or subtler symptoms, and that they're more likely to be managing other medical conditions or pain that can feed into depression. Standard treatment usually involves psychotherapy, medication, or both, chosen together with a health care provider based on a person's needs and situation. That foundation is exactly where a supportive add-on like probiotics might one day fit, if larger studies bear the early findings out.
This is general health information, not medical advice. In this trial, probiotics were an add-on to standard care, never a replacement for it. If you're curious about supplements, it's worth talking with your doctor or pharmacist before starting, stopping, or changing any medication or probiotic — especially alongside antidepressants.
For now, the honest summary is that this is a small, single-region pilot with real limits. More than half of the participants dropped out over the 24 weeks. The advantage over placebo was modest, it didn't extend to quality of life, and the results come from two centers in one country, so they may not carry over to everyone. The researchers themselves are the first to call for more work — and they see a bigger reason to do it. "My vision is to develop affordable healthcare solutions and make them available to the larger population for meaningful public health impact," said co-corresponding author Dr. Abhinaba Ghosh, a physician-neuroscientist at Tata Medical Center in Kolkata. A larger follow-up trial is already in the plans. Until then, this is a hopeful thread to watch rather than a shopping list — and if you'd like food-first ideas in the meantime, our roundup of foods that help support mood and ease depression is a gentle place to start.
Stay on top of health & wellness news
About the Author
Angela Nightingale is a Senior Editor at Daily Vitality with over two decades of experience in digital publishing and health and wellness content. She specializes in turning complex, often-confusing health topics into clear, calm, and practical guidance that respects the reader's intelligence. Her work focuses on helping people feel informed and confident — never overwhelmed or alarmed — as they make everyday decisions about how they eat, move, rest, and age.
